Drugmaker that targeted dementia patients to pay $116 million

cnn.com - Nuedexta, which hit the market in 2011, is only approved by the federal government for a rare condition characterized by uncontrollable laughing and crying, known as pseudobulbar affect, or PBA. Emai…

Tweeted by @Emanci_Payte https://twitter.com/Emanci_Payte/status/1177626818024574976